$0.5390
-0.00210-0.39%
At close: -
$0.5383
-0.00070-0.13%
After Hours: 6:19 PM EDT
Marinus Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Marinus Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.42 | $-0.41 | -2.44 % |
Q2 | 2024-08-13 | $-0.63 | $-0.59 | -6.78 % |
Q1 | 2024-05-08 | $-0.68 | $-0.66 | -3.03 % |
Q4 | 2024-03-05 | $-0.74 | $-0.62 | -19.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $8.54M | $9.42M | -9.31 % |
Q2 | 2024-08-13 | $8.06M | $9.49M | -15.1 % |
Q1 | 2024-05-08 | $7.68M | $9.12M | -15.8 % |
Q4 | 2024-03-05 | $7.19M | $8.01M | -10.2 % |
Marinus Pharma (MRNS) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.42, which missed the estimate of $-0.41.
The Actual Revenue was $8.5M, which missed the estimate of $9.4M.
Browse earnings estimates, EPS, and revenue on all stocks.